Quality of life and wellbeing among breast cancer patients in Lahore, Pakistan

被引:3
作者
Ayub, Fiza [1 ]
Khan, Tahir Mehmood [1 ]
Baig, Mirza Rafi [2 ]
Amin, Muhammad Usman [3 ]
Tahir, Humera [4 ]
机构
[1] Univ Vet & Anim Sci UVAS, Inst Pharmaceut Sci, Lahore, Pakistan
[2] Dubai Pharm Coll Girls, Dept Clin Pharm & Pharmacotherapeut, Dubai, U Arab Emirates
[3] Abasyn Univ, Dept Pharm, Peshawar, Pakistan
[4] Ruth Pfau Coll Nutr Sci, Lahore Med & Dent Coll, Lahore, Pakistan
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
quality of Life; breast cancer; Pakistan; symptom prevalence; FACIT-B; ADVERSE DRUG-REACTIONS; FINANCIAL TOXICITY; CLINICAL-TRIALS; CHEMOTHERAPY; SURVIVORS; WOMEN; INTERVENTIONS; BURDEN; NUMBER; ADULTS;
D O I
10.3389/fonc.2023.1105411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBreast cancer has a high incidence rate, emphasizing the necessity of enhanced information on health-related quality of life (HrQOL) in this population of patients. The aim of this study was to identify the factors influencing the QOL experienced by patients in Pakistan. MethodsA cross-sectional study was conducted on women with breast cancer, and four instruments were used on a random sample of 130 Pakistani women: FACIT-B Version 4 questionnaire,WHO causality assessment scale, Naranjo's algorithm, and a demographic/clinical characteristics section. Data analysis included descriptive analysis, independent sample t-test, and analysis of variance (ANOVA) test. ResultsThe patients' mean age was 49.10 (standard deviation (SD) 10.89); 98.5% were married. The mean score was 18.34 for physical wellbeing (SD 5.92; interquartile range (IQR) 11), 16.33 for social/family wellbeing (SD 6.3; IQR 11.25), 13.6 for emotional wellbeing (SD 3.55; IQR 6), 17.13 for functional wellbeing (SD 3.73; IQR 6), and 24.86 for breast cancer subscale (SD 3.64; IQR 4). The study found that the age, entitlement, recurrence, marital status, salary, number of doses, duration of cancer treatment, and chemotherapy sessions were significantly related to QOL terms in the assessment of the FACIT-B scale. The WHO causality evaluation scale determined that 78.1% of the responses were "probable" and 20.1% were "possible". According to Naranjo's algorithm assessment scale, 80% of adverse drug reactions (ADRs) were "probable", whereas 18.4% were declared "possible". Chemotherapy-induced anemia was the most often reported ADR in 64.6% of patients, followed by chemotherapy-induced nausea and vomiting (61.5%). ConclusionHealthcare practitioners must acknowledge and take into account the significance of QOL in addition to therapy for breast cancer patients in order to enhance their health. The findings of this study will aid in filling gaps in current unknown knowledge and identifying sites where patients require additional assistance. Because cancer and chemotherapy clearly have a negative impact on individuals' QOL, oncologists must concentrate on strategies that help cancer patients during their sickness and treatment while also enhancing self-care and QOL. Those with cancer will benefit from emotional wellbeing and adaptation to their disease.
引用
收藏
页数:12
相关论文
共 66 条
  • [21] Quality of life (QOL) and symptom burden (SB) in patients with breast cancer
    Hamer, Julia
    McDonald, Rachel
    Zhang, Liying
    Verma, Sunil
    Leahey, Angela
    Ecclestone, Christine
    Bedard, Gillian
    Pulenzas, Natalie
    Bhatia, Anchal
    Chow, Ronald
    DeAngelis, Carlo
    Ellis, Janet
    Rakovitch, Eileen
    Lee, Justin
    Chow, Edward
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 409 - 419
  • [22] Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life
    Hamood, Rola
    Hamood, Hatem
    Merhasin, Ilya
    Keinan-Boker, Lital
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 157 - 169
  • [23] Quality of life of breast and cervical cancer survivors
    Huang, Huei-Ying
    Tsai, Wen-Chen
    Chou, Wen-Yu
    Hung, Yao-Ching
    Liu, Liang-Chih
    Huang, Kuo-Feng
    Wang, Wen-Ching
    Leung, Kam-Wing
    Hsieh, Ruey-Kuen
    Kung, Pei-Tseng
    [J]. BMC WOMENS HEALTH, 2017, 17
  • [24] Hurny C, 1996, LANCET, V347, P1279
  • [25] Jamali J., 2021, J PHARM RES INT
  • [26] Khandelwal S., 2015, INT J PHARM BIO SCI, V6, P233
  • [27] Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study
    Kim, Im-Ryung
    Cho, Juhee
    Choi, Eun-Kyung
    Kwon, In Gak
    Sung, Young Hee
    Lee, Jeong Eon
    Nam, Seok-Jin
    Yang, Jung-Hyun
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1383 - 1388
  • [28] Compassion interventions: The programmes, the evidence, and implications for research and practice
    Kirby, James N.
    [J]. PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 2017, 90 (03) : 432 - 455
  • [29] Koliyakodu PS., 2021, INDIAN J PHARM PRACT, V14, DOI [10.5530/ijopp.14.1.2, DOI 10.5530/IJOPP.14.1.2]
  • [30] Konieczny Magdalena, 2020, Asian Pac J Cancer Prev, V21, P185, DOI 10.31557/APJCP.2020.21.1.185